Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation
Authors:
Open Access
- 1 November 2014
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 743, 106-116
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Mild AsthmaNew England Journal of Medicine, 2013
- Lipoxin A 4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in AsthmaScience Translational Medicine, 2013
- IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the LungsThe Journal of Immunology, 2012
- Severe Asthma with Fungal SensitizationCurrent Allergy and Asthma Reports, 2011
- Alternaria alternataserine proteases induce lung inflammation and airway epithelial cell activation via PAR2American Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- New targets for drug development in asthmaThe Lancet, 2008
- Asthma cases attributable to atopy: Results from the Third National Health and Nutrition Examination SurveyJournal of Allergy and Clinical Immunology, 2007
- Corticosteroids: The drugs to beatEuropean Journal of Pharmacology, 2006
- Sensitivity to fungal allergens is a risk factor for life‐threatening asthmaAllergy, 2000
- Corticosteroid modulation of human, antigen-specific Th1 and Th2 responsesJournal of Allergy and Clinical Immunology, 1997